D. Flesch‐Janys

发表

Large-scale genotyping identifies 41 new loci associated with breast cancer risk

Jaana M. Hartikainen, A. Hofman, A. Uitterlinden, 2013, Nature Genetics.

Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

Jane E. Carpenter, Jaana M. Hartikainen, Sandra L. Halverson, 2015, JNCI Journal of the National Cancer Institute.

Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche

Andrew D. Johnson, Daniel L. Koller, E. Demerath, 2014, Nature.

Jaana M. Hartikainen, S. Cross, M. Beckmann, 2014, PloS one.

Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent

A. Whittemore, S. Cross, M. Beckmann, 2016, PLoS medicine.

Association analysis identifies 65 new breast cancer risk loci

Gary D Bader, Jaana M. Hartikainen, Jeffery M. Meyer, 2017, Nature.

Nature Genetics Advance Online Publication Large-scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility and Brca1-mediated Dna Repair

Andrew D. Johnson, Samuel E. Jones, E. Demerath, 2022 .

Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

Andrew D. Johnson, Samuel E. Jones, E. Demerath, 2015, Nature Genetics.

Identification of Novel Genetic Markers of Breast Cancer Survival

Peter Kraft, Nazneen Rahman, Janet A. Dunn, 2015, Journal of the National Cancer Institute.

A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

Jeffery M. Meyer, Richard T. Barfield, Jack A. Taylor, 2018, Nature Genetics.

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Dong Liang, Jane E. Carpenter, Peter Kraft, 2016 .

Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics

Peter Kraft, Michael Bremer, Simon S. Cross, 2008, PLoS genetics.

A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population

Christiana Kartsonaki, Mads Thomassen, Julian Peto, 2010, Nature Genetics.

Physical Activity and Postmenopausal Breast Cancer: Effect Modification by Breast Cancer Subtypes and Effective Periods in Life

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2008, Cancer Epidemiology Biomarkers & Prevention.

Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1.

Wei Lu, Nina Ditsch, Julian Peto, 2013, American journal of human genetics.

Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers

David N. Rider, L. Kiemeney, R. Vierkant, 2011, PloS one.

Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status

J. Chang-Claude, D. Flesch‐Janys, K. Steindorf, 2009, Cancer Causes & Control.

Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy

R. Eils, J. Chang-Claude, H. Brauch, 2010, International journal of cancer.

Agent Orange in Vietnam. 1995.

D. Flesch‐Janys, J. Dwyer, D. Flesch-Janys, 2014, American journal of public health.

Epidemiological studies on cancer and exposure to dioxins and related compounds

O. Axelson, D. Flesch‐Janys, M. Eriksson, 2012 .

A Comprehensive Multistate Model Analyzing Associations of Various Risk Factors With the Course of Breast Cancer in a Population-Based Cohort of Breast Cancer Cases.

J. Chang-Claude, J. Heinz, A. Rudolph, 2016, American journal of epidemiology.

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

Jane E. Carpenter, Daniel J. Park, Gary K. Chen, 2012, Human molecular genetics.

Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia

Jane E. Carpenter, Jaana M. Hartikainen, A. Whittemore, 2014, Breast Cancer Research.

Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence

V. Beral, Jane Green, R. Collins, 2019, The Lancet.

Polymorphism Thr160Thr in SRD5A1, involved in the progesterone metabolism, modifies postmenopausal breast cancer risk associated with menopausal hormone therapy

J. Chang-Claude, R. Hein, D. Flesch‐Janys, 2011, Breast Cancer Research and Treatment.

CD24 polymorphisms in breast cancer: impact on prognosis and risk

Barbara Burwinkel, Petra Seibold, Andreas Schneeweiss, 2013, Breast Cancer Research and Treatment.

Determinants of newly diagnosed comorbidities among breast cancer survivors

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2014, Journal of Cancer Survivorship.

Association of pre‐diagnosis physical activity with recurrence and mortality among women with breast cancer

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2013, International journal of cancer.

Dietary inflammation potential and postmenopausal breast cancer risk in a German case-control study.

J. Chang-Claude, A. Rudolph, D. Flesch‐Janys, 2015, Breast.

Prognostic impact of surgery for early-stage invasive breast cancer on breast cancer-specific survival, overall survival, and recurrence risk: a population-based analysis

J. Chang-Claude, A. Rudolph, D. Flesch‐Janys, 2018, Breast Cancer Research and Treatment.

Physical activity and endogenous sex hormones in postmenopausal women: to what extent are observed associations confounded or modified by BMI?

J. Chang-Claude, D. Flesch‐Janys, R. Kaaks, 2010, Cancer Causes & Control.

Pre-diagnostic alcohol consumption and postmenopausal breast cancer survival: a prospective patient cohort study

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2012, Breast Cancer Research and Treatment.

Genome-wide association study of germline variants and breast cancer-specific mortality

A. Whittemore, W. Willett, S. Cross, 2019, British Journal of Cancer.

Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study

A. Whittemore, S. Cross, K. Heusinger, 2010, Breast Cancer Research.

Population attributable risk of invasive postmenopausal breast cancer and breast cancer subtypes for modifiable and non-modifiable risk factors.

J. Chang-Claude, R. Hein, D. Flesch‐Janys, 2011, Cancer epidemiology.

The impact of menopausal hormone therapy on the incidence of different breast cancer types--data from the Cancer Registry Hamburg 1991-2006.

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2010, Cancer epidemiology.

Postmenopausal estrogen monotherapy–associated breast cancer risk is modified by CYP17A1_-34_T>C polymorphism

R. Eils, J. Chang-Claude, H. Brauch, 2010, Breast Cancer Research and Treatment.

Determinants of long‐term fatigue in breast cancer survivors: results of a prospective patient cohort study

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2015, Psycho-Oncology.

Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast

Julian Peto, Matthias W. Beckmann, Peter A. Fasching, 2014, PLoS genetics.

The Use of Herbal Preparations to Alleviate Climacteric Disorders and Risk of Postmenopausal Breast Cancer in a German Case-Control Study

W. Ahrens, J. Chang-Claude, D. Flesch‐Janys, 2009, Cancer Epidemiology, Biomarkers & Prevention.

Coffee consumption modifies risk of estrogen-receptor negative breast cancer

Jingmei Li, K. Czene, P. Hall, 2011, Breast Cancer Research.

Immune cell functions in industrial workers after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin: dissociation of antigen-specific T-cell responses in cultures of diluted whole blood and of isolated peripheral blood mononuclear cells.

D. Flesch‐Janys, M. Ernst, I. Morgenstern, 1998, Environmental health perspectives.

Immunologic findings in workers formerly exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin and its congeners.

D. Flesch‐Janys, C. Portier, D. Patterson, 1998, Environmental health perspectives.

The Association Between Dietary Lignans, Phytoestrogen-Rich Foods, and Fiber Intake and Postmenopausal Breast Cancer Risk: A German Case-Control Study

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2012, Nutrition and cancer.

Serum enterolactone and postmenopausal breast cancer risk by estrogen, progesterone and herceptin 2 receptor status

J. Chang-Claude, D. Flesch‐Janys, R. Kaaks, 2012, International journal of cancer.

Association of ESR1 gene tagging SNPs with breast cancer risk.

Julian Peto, Ute Hamann, Peter Devilee, 2009, Human molecular genetics.

A Genome-wide Association Study of Early-Onset Breast Cancer Identifies PFKM as a Novel Breast Cancer Gene and Supports a Common Genetic Spectrum for Breast Cancer at Any Age

Jianxin Shi, Daniel F. Schmidt, Nazneen Rahman, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer

A. Uitterlinden, S. Cross, C. Vachon, 2008 .

Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study

A. Schneeweiss, J. Chang-Claude, R. Hein, 2011, Breast Cancer Research.

Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium

M. Beckmann, P. Fasching, N. Camp, 2009, Cancer Epidemiology Biomarkers & Prevention.

Evidence of Gene–Environment Interactions between Common Breast Cancer Susceptibility Loci and Established Environmental Risk Factors

Patrick Neven, Daniel F. Schmidt, Julian Peto, 2013, PLoS genetics.

Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Patrick Neven, Hui Zhao, Nazneen Rahman, 2012, PloS one.

Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC)

Daniel J. Park, S. Cross, M. Beckmann, 2012, PLoS ONE.

a novel candidate breast cancer susceptibility locus on

S. Cross, K. Czene, P. Hall, 2017 .

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer

Wei Lu, Wei Zheng, Mads Thomassen, 2013, Nature Genetics.

Identiﬁcation of four novel susceptibility loci for oestrogen receptor negative breast cancer

Nussbaum, S. Cross, P. Fasching, 2016 .

Genome-wide association study of germline variants and breast cancer-speci ﬁ c mortality

A. Whittemore, M. Beckmann, A. Talhouk, 2019 .

11q13 is a susceptibility locus for hormone receptor positive breast cancer

Patrick Neven, Michael Jones, Michael Bremer, 2012, Human mutation.

Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer--results of a large case-control study.

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2007, Carcinogenesis.

The Gc 2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk , Independent of the Vitamin D Status

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2008 .

Genomic analyses identify hundreds of variants associated with age at menarche and 1 support a role for puberty timing in cancer risk 2

Maristella, E. Demerath, Toshiko Tanaka, 2017 .

Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies

Heather Eliassen, Karen Canfell, Julian Peto, 2012, The Lancet. Oncology.

Gene–environment interactions involving functional variants: Results from the Breast Cancer Association Consortium

S. Cross, M. Beckmann, P. Fasching, 2017, International journal of cancer.

ELIMINATION OF β-HEXACHLOROCYCLOHEXANE IN OCCUPATIONALLY EXPOSED PERSONS

L. Edler, H. Becher, D. Flesch‐Janys, 1997 .

Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer

S. Cross, M. Beckmann, P. Fasching, 2011, Cancer Epidemiology, Biomarkers & Prevention.

Dioxins and furans: epidemiologic assessment of cancer risks and other human health effects.

H. Becher, D. Flesch‐Janys, Heiko Becher, 1998, Environmental health perspectives.

Enterolactone concentrations and prognosis after postmenopausal breast cancer: Assessment of effect modification and meta‐analysis

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2014, International journal of cancer.

Cancer mortality in workers exposed to phenoxy herbicides, chlorophenols, and dioxins. An expanded and updated international cohort study.

M. Kogevinas, H. Becher, J. Mathews, 1997, American journal of epidemiology.

19p13.1 is a triple-negative-specific breast cancer susceptibility locus.

Daniel J. Park, Julian Peto, Kamila Czene, 2012, Cancer research.

Common breast cancer susceptibility loci are associated with triple-negative breast cancer.

Jane E. Carpenter, S. Cross, M. Beckmann, 2011, Cancer research.

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.

Victoria L. Cafourek, S. Cross, M. Beckmann, 2011, Journal of the National Cancer Institute.

The Gc2 Allele of the Vitamin D Binding Protein Is Associated with a Decreased Postmenopausal Breast Cancer Risk, Independent of the Vitamin D Status

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2008, Cancer Epidemiology Biomarkers & Prevention.

Common germline polymorphisms associated with breast cancer-specific survival

Jaana M. Hartikainen, W. Willett, S. Cross, 2015, Breast Cancer Research.

Genome-wide association study of germline variants and breast cancer-specific mortality

A. Whittemore, W. Willett, S. Cross, 2019, British Journal of Cancer.

Polymorphisms in oxidative stress-related genes and mortality in breast cancer patients--potential differential effects by radiotherapy?

P. Hall, J. Chang-Claude, H. Nevanlinna, 2013, Breast.

Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

Michael Jones, Peter Kraft, Arnaud Droit, 2017, Nature Genetics.

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus

A. Whittemore, L. Kiemeney, S. Cross, 2016, Nature Communications.

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium.

Patrick Neven, Päivi Heikkilä, Giu-Cheng Hsu, 2011, Human molecular genetics.

Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.

Wei Lu, Päivi Heikkilä, Peter Kraft, 2013, American journal of human genetics.

Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.

Peter Kraft, Todd L Edwards, Nazneen Rahman, 2016, Cancer discovery.

Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility

E. Demerath, Toshiko Tanaka, K. Lunetta, 2016, bioRxiv.

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

Jane E. Carpenter, Peter Kraft, Gary K. Chen, 2011, Nature Genetics.

Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer

Patrick Neven, Peter Kraft, Nazneen Rahman, 2015 .

Genome-wide association studies identify four ER negative–specific breast cancer risk loci

Patrick Neven, Michael Jones, Wei Lu, 2013, Nature Genetics.

Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1.

Jaana M. Hartikainen, Sandra L. Halverson, S. Cross, 2015, American journal of human genetics.

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation

Jaana M. Hartikainen, S. Cross, M. Beckmann, 2014, Nature Communications.

BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.

Dong Liang, Patrick Neven, Harvey Risch, 2016, Journal of the National Cancer Institute.

Cross-cancer genome-wide association analysis of lung, ovary, breast, prostate and colon cancer identifies a novel cancer locus at 1q22

Stacey, Ali Amin Al Olama, Nilanjan, 2015 .

Germline variants of base excision repair genes and breast cancer: A polymorphism in DNA polymerase gamma modifies gene expression and breast cancer risk

J. Chang-Claude, C. Plass, D. Flesch‐Janys, 2013, International journal of cancer.

7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium

R. Schulz-Wendtland, M. Beckmann, P. Fasching, 2011, Journal of Medical Genetics.

Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis.

J. Chang-Claude, J. Hopper, A. Spurdle, 2008, Journal of the National Cancer Institute.

Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer.

Jaana M. Hartikainen, Kristen S Purrington, S. Cross, 2015, Carcinogenesis.

Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

Jane E. Carpenter, Kyriaki Michailidou, France Labrèche, 2014, Human molecular genetics.

Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization.

Jaana M. Hartikainen, A. Whittemore, S. Cross, 2015, Journal of the National Cancer Institute.

Genome-wide association analysis identifies three new breast cancer susceptibility loci

Michael Jones, Nazneen Rahman, Daniel J. Park, 2012, Nature Genetics.

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Jane E. Carpenter, A. Whittemore, W. Chung, 2016, Nature Communications.

Cross-Cancer Genome-Wide Analysis of Lung, Ovary, Breast, Prostate, and Colorectal Cancer Reveals Novel Pleiotropic Associations.

Steven Gallinger, Peter Kraft, Nazneen Rahman, 2016, Cancer research.

Identiﬁcation and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

S. Cross, M. Beckmann, P. Fasching, 2022 .

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Jane E. Carpenter, Kristen S Purrington, Victoria L. Cafourek, 2014, Carcinogenesis.

Identification and characterization of novel associations in the CASP 8 / ALS 2 CR 12 region on chromosome 2 with breast cancer risk

Jaana M. Hartikainen, Halverson, Kristen S Purrington, 2014 .

No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.

Sandra L. Halverson, A. Whittemore, L. Kiemeney, 2016, Gynecologic oncology.

Exposure to dioxin and nonneoplastic mortality in the expanded IARC international cohort study of phenoxy herbicide and chlorophenol production workers and sprayers.

M. Kogevinas, H. Becher, J. Mathews, 1998, Environmental health perspectives.

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

Jaana M. Hartikainen, S. Cross, M. Beckmann, 2015, Human molecular genetics.

Genetic variation at CYP 3 A is associated with age at menarche and breast cancer risk : a case-control study

Jaana M. Hartikainen, S. Cross, M. Beckmann, 2014 .

Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study

Patrick Neven, Chiun-Sheng Huang, Julian Peto, 2014, Breast Cancer Research.

9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium

S. Cross, R. Schulz-Wendtland, M. Beckmann, 2012, Cancer Epidemiology, Biomarkers & Prevention.

PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

S. Cross, M. Beckmann, P. Fasching, 2017, Oncotarget.

Fine-mapping identi fi es two additional breast cancer susceptibility loci at 9 q 31 . 2

Jaana M. Hartikainen, M. Beckmann, P. Fasching, 2015 .

Deregulated serum concentrations of circulating cell-free microRNAs miR-17, miR-34a, miR-155, and miR-373 in human breast cancer development and progression.

J. Chang-Claude, D. Flesch‐Janys, K. Pantel, 2013, Clinical chemistry.

Menopausal Hormone Therapy and Risk of Clinical Breast Cancer Subtypes

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2009, Cancer Epidemiology Biomarkers & Prevention.

Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions

Patrick Neven, Michael Jones, Julian Peto, 2014, Genetic epidemiology.

the Breast Cancer Association Consortium Five Polymorphisms and Breast Cancer Risk : Results from Updated

M. Beckmann, P. Fasching, N. Camp, 2009 .

Serum enterolactone and prognosis of postmenopausal breast cancer.

J. Chang-Claude, D. Flesch‐Janys, R. Kaaks, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Body mass index and breast cancer survival: a Mendelian randomization analysis

Jaana M. Hartikainen, W. Willett, S. Cross, 2017, International journal of epidemiology.

Parent-of-Origin Specific Allelic Associations Among 106 Genomic Loci for Age at Menarche

Andrew D. Johnson, Daniel L. Koller, E. Demerath, 2014 .

Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

Jaana M. Hartikainen, S. Cross, P. Fasching, 2015, Human Genetics.

11q13 is a susceptibility locus for hormone receptor positive breast cancer

Jaana M. Hartikainen, S. Cross, R. Schulz-Wendtland, 2012, Human mutation.

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11.

Jane E. Carpenter, Daniel J. Park, Gary K. Chen, 2012, Human molecular genetics.

A polymorphism in the base excision repair gene PARP2 is associated with differential prognosis by chemotherapy among postmenopausal breast cancer patients

Jaana M. Hartikainen, Kristen S Purrington, A. Børresen-Dale, 2015, BMC Cancer.

Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

Thomas Brüning, Kamila Czene, Ute Hamann, 2015, International journal of cancer.

Polymorphisms in the Gene Regions of the Adaptor Complex LAMTOR2/LAMTOR3 and Their Association with Breast Cancer Risk

F. Kronenberg, J. Chang-Claude, S. Coassin, 2013, PloS one.

Agent Orange in Vietnam.

D. Flesch‐Janys, J. Dwyer, D. Flesch-Janys, 1995, American journal of public health.

A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium.

Julian Peto, Kyriaki Michailidou, Thomas Brüning, 2014, Human molecular genetics.

Polymorphisms in the BRCA1 and ABCB1 genes modulate menopausal hormone therapy associated breast cancer risk in postmenopausal women

R. Eils, J. Chang-Claude, H. Brauch, 2010, Breast Cancer Research and Treatment.

Good agreement between physician and self-reported hormone therapy data in a case-control study.

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2007, Journal of clinical epidemiology.

Estimated enterolignans, lignan-rich foods, and fibre in relation to survival after postmenopausal breast cancer

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2011, British Journal of Cancer.

Body mass index and breast cancer survival: a Mendelian randomization analysis

W. Willett, S. Cross, P. Fasching, 2017, International Journal of Epidemiology.

Body mass index and breast cancer survival

S. Cross, P. Fasching, Jingmei Li, 2017 .

Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

Jaana M. Hartikainen, Kristen S Purrington, Ali Amin Al Olama, 2014, Human molecular genetics.

A Genome-Wide “Pleiotropy Scan” Does Not Identify New Susceptibility Loci for Estrogen Receptor Negative Breast Cancer

W. Willett, J. Chang-Claude, S. Chanock, 2014, PloS one.

Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2008, International journal of cancer.

Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry

A. Whittemore, S. Cross, M. Beckmann, 2016, Cancer Causes & Control.

The UGT1A6_19_GG genotype is a breast cancer risk factor

Peter A. Fasching, Thomas Brüning, Beate Pesch, 2013, Front. Genet..

2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy

Matthias W. Beckmann, Peter A. Fasching, Nur Aishah Mohd Taib, 2014, Nature Communications.

Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study.

A. Ashworth, C. Vachon, K. Czene, 2013, Endocrine-related cancer.

A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication

Jingmei Li, K. Czene, P. Hall, 2013, Breast Cancer Research and Treatment.

Fatigue and quality of life in breast cancer survivors: temporal courses and long-term pattern

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2012, Journal of Cancer Survivorship.

Cancer mortality among workers in chemical plant contaminated with dioxin

D. Flesch‐Janys, J. Dwyer, J. Berger, 1991, The Lancet.

Quantitative cancer risk assessment for dioxins using an occupational cohort.

H. Becher, D. Flesch‐Janys, K. Steindorf, 1998, Environmental health perspectives.

Relationship between menopausal hormone therapy and mortality after breast cancer The MARIEplus study, a prospective case cohort

J. Chang-Claude, J. Heinz, A. Rudolph, 2015, International journal of cancer.

FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium

Kristen S Purrington, P. Fasching, A. Ashworth, 2014, British Journal of Cancer.

Physical Activity and Postmeno - pausal Breast Cancer Effect Modification by Other Breast Cancer Risk Factors

J. Chang-Claude, D. Flesch‐Janys, K. Steindorf, 2017 .

Physical Activity and Postmenopausal Breast Cancer

J. Chang-Claude, D. Flesch‐Janys, K. Steindorf, 2009, Methods of Information in Medicine.

Elimination of polychlorinated dibenzo-p-dioxins and dibenzofurans in occupationally exposed persons.

H. Becher, D. Flesch‐Janys, O. Päpke, 1996, Journal of toxicology and environmental health.

Estimation of the cumulated exposure to polychlorinated dibenzo-p-dioxins/furans and standardized mortality ratio analysis of cancer mortality by dose in an occupationally exposed cohort.

H. Becher, D. Flesch‐Janys, K. Steindorf, 1998, Environmental health perspectives.

Mortality and Recurrence Risk in Relation to the Use of Lipid-Lowering Drugs in a Prospective Breast Cancer Patient Cohort

J. Chang-Claude, J. Heinz, S. Nickels, 2013, PloS one.

Cancer mortality in German male workers exposed to phenoxy herbicides and dioxins

M. Kogevinas, H. Becher, D. Flesch‐Janys, 1996, Cancer Causes & Control.

Quantification of exposure to dioxins and furans in a cohort of workers of a herbicide producing plant in hamburg, FRG

D. Flesch‐Janys, J. Wahrendorf, J. Konietzko, 1992 .

Antioxidant supplementation and breast cancer prognosis in postmenopausal women undergoing chemotherapy and radiation therapy.

J. Chang-Claude, D. Flesch‐Janys, A. Jung, 2019, The American journal of clinical nutrition.

Pre-diagnostic smoking behaviour and poorer prognosis in a German breast cancer patient cohort - Differential effects by tumour subtype, NAT2 status, BMI and alcohol intake.

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2014, Cancer epidemiology.

Exposure to polychlorinated dioxins and furans (PCDD/F) and mortality in a cohort of workers from a herbicide-producing plant in Hamburg, Federal Republic of Germany.

D. Flesch‐Janys, J. Dwyer, J. Berger, 1995, American journal of epidemiology.

Elimination of beta-hexachlorocyclohexane in occupationally exposed persons.

H. Becher, D. Flesch‐Janys, L. Edler, 1997, Journal of toxicology and environmental health.

Confirmation of the reduction of hormone replacement therapy-related breast cancer risk for carriers of the HSD17B1_937_G variant

Jingmei Li, P. Hall, K. Humphreys, 2013, Breast Cancer Research and Treatment.

Associations between adjuvant radiotherapy and different causes of death in a German breast cancer cohort.

J. Chang-Claude, D. Flesch‐Janys, P. Seibold, 2018, Breast.

Test-retest reliability of self-reported reproductive and lifestyle data in the context of a German case-control study on breast cancer and postmenopausal hormone therapy.

Dieter Flesch-Janys, Jenny Chang-Claude, J. Chang-Claude, 2007, Annals of epidemiology.

Dietary patterns and the risk of postmenopausal breast cancer in a German case–control study

J. Chang-Claude, D. Flesch‐Janys, A. Vrieling, 2011, Cancer Causes & Control.

Dietary patterns and survival in German postmenopausal breast cancer survivors

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2012, British Journal of Cancer.

Collection of vaccination data in the German National Cohort

M. Akmatov, W. Ahrens, A. Karch, 2014, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

Serum 25-hydroxyvitamin D and risk of postmenopausal breast cancer-results of a large case-control study

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2007 .

Circulating 25‐hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?

J. Chang-Claude, J. Heinz, D. Flesch‐Janys, 2014, International journal of cancer.

Evaluation of a questionnaire to assess selected infectious diseases and their risk factors

M. Akmatov, W. Ahrens, L. Kreienbrock, 2014, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

Determinants of sports, cycling, walking and overall leisure-time physical activity among postmenopausal women in Germany

J. Chang-Claude, D. Flesch‐Janys, K. Steindorf, 2010, Public Health Nutrition.

Anti-nuclear autoantibodies in the general German population: prevalence and lack of association with selected cardiovascular and metabolic disorders—findings of a multicenter population-based study

J. Linseisen, M. Akmatov, W. Ahrens, 2017, Arthritis Research & Therapy.

Circulating enterolactone concentrations and prognosis of postmenopausal breast cancer: assessment of mediation by inflammatory markers

J. Chang-Claude, D. Flesch‐Janys, R. Kaaks, 2018, International journal of cancer.

Vitamin D receptor gene polymorphisms and haplotypes and postmenopausal breast cancer risk

J. Chang-Claude, D. Flesch‐Janys, S. Kropp, 2008, Breast Cancer Research.

Determination of nasal and oropharyngeal microbiomes in a multicenter population-based study – findings from Pretest 1 of the German National Cohort

J. Linseisen, C. Meisinger, M. Akmatov, 2017, Scientific Reports.

Limitations of epidemiology in assessing cancer risk from environmental sources.

D. Flesch‐Janys, H. Neus, M. Schümann, 1989, Experimental pathology.

Feasibility and acceptance of cervicovaginal self-sampling within the German National Cohort (Pretest 2)

D. Flesch‐Janys, M. Pawlita, M. Schmitt, 2014, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz.

Molecular and Cellular Pathobiology 19 p 13 . 1 Is a Triple-Negative – Speci fi c Breast Cancer Susceptibility Locus

Xiaoqing, Daniel J. Park, Arif, 2012 .

Estimation of dioxin and furan elimination rates with a pharmacokinetic model

D. Flesch‐Janys, W. Slob, J. Wittsiepe, 2000, Journal of Exposure Analysis and Environmental Epidemiology.

Mortality and life expectancy of professional fire fighters in Hamburg, Germany: a cohort study 1950 – 2000

Peter Koch, Dieter Flesch-Janys, Norbert L Wagner, 2006, Environmental health : a global access science source.

Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair

Andrew D. Johnson, E. Demerath, Toshiko Tanaka, 2015 .

PALB2,CHEK2 and ATM rare variants and cancer risk: Data from COGS

Jane E. Carpenter, Lara E Sucheston-Campbell, Ali Amin Al Olama, 2016 .

Nature Genetics Advance Online Publication Large-scale Genomic Analyses Link Reproductive Aging to Hypothalamic Signaling, Breast Cancer Susceptibility and Brca1-mediated Dna Repair

D. J. Thompson, E. Demerath, K. Lunetta, 2022 .

Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche

John P. Rice, Daniel L. Koller, D. J. Thompson, 2014, Nature.

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

Jane E. Carpenter, Lara E Sucheston-Campbell, A. Whittemore, 2016, Journal of Medical Genetics.